Acer Therapeutics is based in Los Angeles, California. It has raised $17M in total funding. Latest round: Growth. Backed by TVM Capital Life Sciences.
Acer Therapeutics funding overview
Acer Therapeutics is based in Los Angeles, California. Acer Therapeutics has raised $17M in total disclosed funding. That places its disclosed total in the $1M–$25M range. Its most recent disclosed round is a Growth announced in November 2022. The round record for Acer Therapeutics runs through 2022; nothing later has been disclosed. Investors on record include TVM Capital Life Sciences.
Acer Therapeutics at a glance
Total raised
$17M
Latest round
Growth
Latest round date
November 2022
Headquarters
Los Angeles, California
Notable investors
TVM Capital Life Sciences
Frequently asked about Acer Therapeutics funding
How much has Acer Therapeutics raised?
Acer Therapeutics has raised $17M in total disclosed funding across the rounds on record.
Who has invested in Acer Therapeutics?
TVM Capital Life Sciences are named among the investors backing Acer Therapeutics.
What was the latest Acer Therapeutics funding round?
The most recent disclosed round is a Growth, announced in November 2022.
Where is Acer Therapeutics based?
Acer Therapeutics is based in Los Angeles, California.
When did Acer Therapeutics last raise?
The last disclosed Acer Therapeutics round closed in November 2022 at Growth.
Totals shown for Acer Therapeutics aggregate every disclosed round on file. To see how that compares, browse the companies in Los Angeles and the investors behind them below.
